Collegium Pharmaceutical (COLL) PT Lowered to $48 at Barclays
Tweet
Share
E-mailGet Alerts COLL Hot Sheet
Price: $24.00 -2.48%
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Barclays analyst Glen Santangelo lowered the price target on Collegium Pharmaceutical (NASDAQ: COLL) to $48.00 (from $56.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Ecopetrol SA (ECOPETL:CB) (EC) PT Raised to $2,970 at JPMorgan
- Petroleo Brasileiro SA (PETR4:BZ) (PBR) PT Raised to R$58.50 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
